The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial

BACKGROUND: The balANZ trial recently reported that neutral pH, low glucose degradation product (biocompatible) peritoneal dialysis (PD) solutions significantly delayed anuria and reduced peritonitis rates compared with conventional solutions. This article reports a secondary outcome analysis of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, David W., Brown, Fiona G., Clarke, Margaret, Boudville, Neil, Elias, Tony J., Foo, Marjorie W.Y., Jones, Bernard, Kulkarni, Hemant, Langham, Robyn, Ranganathan, Dwarakanathan, Schollum, John, Suranyi, Michael G., Tan, Seng H., Voss, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520083/
https://www.ncbi.nlm.nih.gov/pubmed/22859794
http://dx.doi.org/10.1093/ndt/gfs314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520083/
https://www.ncbi.nlm.nih.gov/pubmed/22859794
http://dx.doi.org/10.1093/ndt/gfs314

Ejemplares similares